T3D THERAPEUTICS, INC.

Profile

Company Names

T3D THERAPEUTICS, INC.

Addresses

68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC 27709

68 T.W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC 27709

68 T. W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC 27709

Phone Numbers

919-237-4897
919-949-0517

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$30,022,185.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2022-08-26 
$6,002,712.00 
$7,500,000.00 
$1,497,288.00 
Equity 
6
2019-10-25 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
5
2018-03-02 
$6,000,000.00 
$18,000,000.00 
$12,000,000.00 
Equity 
4
2018-01-05 
$711,270.00 
$1,000,000.00 
$288,730.00 
Debt 
3
2015-02-26 
$1,210,206.00 
$3,750,200.00 
$2,539,994.00 
Equity 
2
2014-03-01 
$660,997.00 
$2,500,000.00 
$1,839,003.00 
Equity 
1
2013-06-19 
$437,000.00 
$550,000.00 
$113,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
DIDSBURY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JOHN 
A. 
GOLDEN 
DIRECTOR
DAVID 
 
KEIM 
DIRECTOR
CHARLES 
 
LINEBERRY 
DIRECTOR
TOM 
 
MENDELL 
DIRECTOR
DONALD 
 
PARKER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-05 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
N/A
NONE
ROI CAPITAL PARTNERS, LLC
NONE